Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.010 UNCHANGED
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
37 38 Next >
Don’t Let Misconduct Allegations Cloud Your Perception of SAVA Stock
It's easy to get mired in the controversy surrounding Cassava Sciences, but distracted SAVA stock traders might miss an opportunity. 
Via InvestorPlace
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of... 
Via Benzinga
3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
Here is a look at three names that buy-and-hold investors may want to consider as the race to find a cure for Alzheimer's disease accelerates 
Via MarketBeat
2 Signals to Watch Before Buying SAVA Stock
SAVA stock got ahead of itself in September, but if it continues to pull back, a solid entry point could emerge for this risky biotech play. 
Via InvestorPlace
EXCLUSIVE: Top 10 Stocks Searched On Benzinga Pro In September: Where Do Tesla, Apple, Bed Bath & Beyond Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga
$100 Invested In Cassava Sciences 15 Years Ago Would Be Worth This Much Today
Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 15 years by 3.29% on an annualized basis producing an average annual return of 9.08%. Currently, Cassava Sciences has a market... 
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $10,000 Today
Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 20 years by 4.23% on an annualized basis producing an average annual return of 12.02%. Currently, Cassava Sciences has a market... 
Via Benzinga
How High Can SAVA Stock Go Once the Controversy Clears?
If a reproduced SEC letter concerning Cassava Sciences' clearance is legit, SAVA stock could head much higher. 
Via InvestorPlace
'Right Now, You've Still Got To Avoid The Stock,' Jim Cramer Says About This Aerospace Company
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Sherwin-Williams Co (NYSE: SHW) might go lower as the PE (price-to-earnings) multiple is still "way too high" on the stock. 
Via Benzinga
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
Via Benzinga
Why Is Acumen (ABOS) Stock Up 95% Today?
Acumen Pharmaceuticals (ABOS) stock is rocketing higher on Wednesday but it's not due to any recent news from the company. 
Via InvestorPlace
What Is Going on With Silo Pharma (SILO) Stock Today?
Silo Pharma (SILO) stock is in the news Wednesday as investors react to the company uplisting shares to the Nasdaq Exchange. 
Via InvestorPlace
Why Is Taiwan Semiconductor (TSM) Stock Down Today?
Taiwan Semiconductor (TSM) stock isn't doing so hot Wednesday on reports that Apple (AAPL) is decreasing production for the iPhone 14. 
Via InvestorPlace
Why Is Cassava Sciences (SAVA) Stock Heating Up Today?
SAVA stock rose 5% on the success of Biogen in slowing cognitive decline from Alzheimer's, but its Simufilam has a different target. 
Via InvestorPlace
US Stocks Mixed; Wholesale Inventories Increase 1.3% In August
U.S. stocks traded mixed this morning, with the Dow Jones gaining around 20 points on Wednesday. 
Via Benzinga
Why Cassava Sciences Shares Are Soaring Higher
Cassava Sciences Inc (NASDAQ: SAVA) shares are trading higher by 7.15 to $49.48 during Wednesday's pre-market session after Biogen Inc (NASDAQ: BIIB) and Eisai Co. 
Via Benzinga
Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket
Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday. 
Via Benzinga
Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks moving higher in today’s pre-market trading session. 
Via Benzinga
Caution! It’s Not Safe to Jump on the SAVA Stock Hype Train.
Rumors and speculation surrounding Cassava Sciences incited a buying frenzy in SAVA stock, but this isn't the time to jump on the hype train. 
Via InvestorPlace
US Stocks Open Higher; Dow Surges 300 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Tuesday. 
Via Benzinga
US Stocks Mostly Higher; Nasdaq Rises Over 100 Points
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday. 
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Friday, 9/23, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
BP, Costco, FedEx And Other Big Losers From Friday
U.S. stocks closed lower with the Nasdaq Composite dropping around 200 points on Friday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers 
Via Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday. 
Via Benzinga
5 Investors Betting Big on Cassava (SAVA) Stock
SAVA stock received a boost yesterday following news that the SEC had closed its case against the company. Here are its top five investors. 
Via InvestorPlace
Pain Therapeutics Stock Shows Rising Price Performance With Jump To 97 RS Rating
Pain Therapeutics sees its Relative Strength Rating enter the elite 90-plus level. 
Via Investor's Business Daily
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day... 
Via Benzinga
Nasdaq Tumbles Over 200 Points; Crude Oil Drops Sharply
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Friday. 
Via Benzinga
US Stocks Open Lower; Dow Tumbles 400 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping around 400 points on Friday. 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS